A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
Clinical trial NCT03770780 · COMPLETED
Trial details
- NCT number
- NCT03770780
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2019-03-08
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.